Skip to main content
. 2019 Feb 26;8(3):200. doi: 10.3390/cells8030200

Figure 1.

Figure 1

Paradigm for use and definition of biomarkers in clinical trials. Validation of a biomarker to be considered integral to a clinical trial from its pre-clinical definition. Slide courtesy of Dr. A. Oza from his presentation to the Gynecologic Cancer InterGroup (GCIG) Translational Research brainstorming day.